Most Popular
-
1
Exports to US reach all-time high, widen gap with China
-
2
Trump rekindles criticism: US forces defending 'wealthy' S. Korea 'free of charge'
-
3
[Music in drama] Rekindle a love that slipped through your fingers
![[Music in drama] Rekindle a love that slipped through your fingers](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/01/20240501050484_0.jpg&u=20240501151646)
-
4
S. Korea discussed possible participation in AUKUS Pillar 2 with Australia: defense minister
-
5
[New faces of Assembly] Architect behind ‘audacious initiative’ believes in denuclearized North Korea
![[New faces of Assembly] Architect behind ‘audacious initiative’ believes in denuclearized North Korea](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/01/20240501050627_0.jpg&u=20240502093000)
![[Music in drama] Rekindle a love that slipped through your fingers](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/01/20240501050484_0.jpg&u=20240501151646)
![[New faces of Assembly] Architect behind ‘audacious initiative’ believes in denuclearized North Korea](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/01/20240501050627_0.jpg&u=20240502093000)
-
6
Seoul Metro to seek legal action against malicious complaints
-
7
On May Day, labor unions blast Yoon's foreign nanny proposal
-
8
Illit, mired in controversy, remains on Billboard charts for 5th week
-
9
Opposition-led Assembly unilaterally passes bill to probe Marine's death
-
10
[KH Explains] Will alternative trading platform shake up Korean stock market?
![[KH Explains] Will alternative trading platform shake up Korean stock market?](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/01/20240501050557_0.jpg&u=20240501161906)
![[KH Explains] Will alternative trading platform shake up Korean stock market?](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/01/20240501050557_0.jpg&u=20240501161906)
[THE INVESTOR] Samsung BioLogics on Aug. 12 applied to the Korea Exchange for a preliminary listing review.
The world’s third largest biologics contract manufacturer by capacity will be the first pharmaceutical firm to be listed on the benchmark KOPSI in 10 years.
The company is 51 percent held by Samsung C&T, and 46.8 percent by Samsung Electronics.
The world’s third largest biologics contract manufacturer by capacity will be the first pharmaceutical firm to be listed on the benchmark KOPSI in 10 years.
The company is 51 percent held by Samsung C&T, and 46.8 percent by Samsung Electronics.
Samsung BioLogics is expected to be the largest IPO this year. The industry estimates subscription of about 3 trillion won (US$2.72 billion), with the firm’s market capitalization likely to exceed 10 trillion won.
According to reports, the firm plans to use the capital raised through the IPO to increase its annual production capacity to 360,000 liters by 2018. Its current production capacity stands at 180,000 liters.
Last year, the company posted revenue of 91.3 billion won, and net profit of about 1.9 trillion won.
By Choi He-suk (cheesuk@heraldcorp.com)
![[Today’s K-pop] Stray Kids go gold in US with ‘Maniac’](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/05/02/20240502050771_0.jpg&u=)